Cochlear (ASX:COH) is a world leader in restoring hearing to profoundly hearing-impaired patients.
The company currently occupies a 70% share of the world market for the profoundly hearing impaired (PHI), selling its products in over 100 countries.
COH shares have been smashed today after the group recalled its latest hearing implant range.
The voluntary recall of COH’s Nucleus CI500 range was in response to a recent increase in implant failures.
The group’s shares have been trading lower by more than 20% so far today, making COH the worst performer in the stock market.
Written by: admin Other posts from: admin
Posted in ASX Top 200 XJO, ASX Top 500 All Ordinaries, Financial News, Health Care Stocks, Market Sectors News, S&P ASX News, Watch Stocks